Suvretta Capital Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $2.33 Billion distributed in 101 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kura Oncology, Inc. with a value of $151M, Arcellx, Inc. with a value of $109M, Meta Platforms, Inc. with a value of $84.3M, Ultragenyx Pharmaceutical Inc. with a value of $78.3M, and Arcutis Biotherapeutics, Inc. with a value of $78.1M.

Examining the 13F form we can see an increase of $410M in the current position value, from $1.92B to 2.33B.

Suvretta Capital Management, LLC is based out at New York, NY

Below you can find more details about Suvretta Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.33 Billion
Healthcare: $1.28 Billion
ETFs: $322 Million
Technology: $211 Million
Communication Services: $190 Million
Consumer Cyclical: $120 Million
Financial Services: $88.3 Million
Industrials: $87.6 Million
Consumer Defensive: $33.4 Million
Other: $1.84 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 101
  • Current Value $2.33 Billion
  • Prior Value $1.92 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 23 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.